Shue Youe Kong 4
4 · OPTIMER PHARMACEUTICALS INC · Filed Dec 2, 2009
Insider Transaction Report
Form 4
Shue Youe Kong
VP, clinical Development
Transactions
- Purchase
Common Stock
2009-12-02$10.89/sh+500$5,445→ 82,648 total - Purchase
Common Stock
2009-12-01$11.10/sh+1,000$11,100→ 80,648 total - Purchase
Common Stock
2009-12-02$10.90/sh+500$5,450→ 82,148 total - Purchase
Common Stock
2009-12-02$10.96/sh+1,000$10,960→ 81,648 total
Footnotes (1)
- [F1]Owned jointly with spouse.